Screener
Disc Medicine IRON Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205192
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other income (expense), net: | ||
| Interest income | 6,893 | 6,880 |
| Interest expense | (844) | (897) |
| Other income (expense) | 22 | (3) |
| Total other income (expense), net | 6,071 | 5,980 |
| Loss before income taxes | (63,453) | (33,966) |
| Income tax expense | (51) | (119) |
| Net loss | $(63,504) | $(34,085) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Disc Medicine's other income, net (note 6)?
- Disc Medicine (IRON) reported other income, net (note 6) of $22K in Q1 2026.
- How has Disc Medicine's other income, net (note 6) changed year-over-year?
- Disc Medicine's other income, net (note 6) increased by 833.3% year-over-year, from -$3K to $22K.
- What is the long-term trend for Disc Medicine's other income, net (note 6)?
- Over 3 years (2021 to 2025), Disc Medicine's other income, net (note 6) has grown at a 53.5% compound annual growth rate (CAGR), from -$13K to $47K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.
Ask your AI about Disc Medicine's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude